These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Alport syndrome with diffuse leiomyomatosis. When and when not? Miner JH Am J Pathol; 1999 Jun; 154(6):1633-5. PubMed ID: 10362786 [No Abstract] [Full Text] [Related]
43. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419 [TBL] [Abstract][Full Text] [Related]
44. Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression. Antignac C; Knebelmann B; Drouot L; Gros F; Deschênes G; Hors-Cayla MC; Zhou J; Tryggvason K; Grünfeld JP; Broyer M J Clin Invest; 1994 Mar; 93(3):1195-207. PubMed ID: 8132760 [TBL] [Abstract][Full Text] [Related]
45. A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia. Arrondel C; Deschênes G; Le Meur Y; Viau A; Cordonnier C; Fournier A; Amadeo S; Gubler MC; Antignac C; Heidet L Kidney Int; 2004 Jun; 65(6):2030-40. PubMed ID: 15149316 [TBL] [Abstract][Full Text] [Related]
46. X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. Renieri A; Bruttini M; Galli L; Zanelli P; Neri T; Rossetti S; Turco A; Heiskari N; Zhou J; Gusmano R; Massella L; Banfi G; Scolari F; Sessa A; Rizzoni G; Tryggvason K; Pignatti PF; Savi M; Ballabio A; De Marchi M Am J Hum Genet; 1996 Jun; 58(6):1192-204. PubMed ID: 8651296 [TBL] [Abstract][Full Text] [Related]
47. Alport syndrome caused by a 5' deletion within the COL4A5 gene. Renieri A; Seri M; Myers JC; Pihlajaniemi T; Sessa A; Rizzoni G; De Marchi M Hum Genet; 1992 Apr; 89(1):120-1. PubMed ID: 1577459 [TBL] [Abstract][Full Text] [Related]
48. Detection of mutations in COL4A5 in patients with Alport syndrome. Plant KE; Green PM; Vetrie D; Flinter FA Hum Mutat; 1999; 13(2):124-32. PubMed ID: 10094548 [TBL] [Abstract][Full Text] [Related]
49. Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport syndrome. Japanese Alport Network. Naito I; Kawai S; Nomura S; Sado Y; Osawa G Kidney Int; 1996 Jul; 50(1):304-11. PubMed ID: 8807602 [TBL] [Abstract][Full Text] [Related]
50. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains]. Heidet L; Gubler MC Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395 [TBL] [Abstract][Full Text] [Related]
51. Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys. Heidet L; Cai Y; Guicharnaud L; Antignac C; Gubler MC Am J Pathol; 2000 Jun; 156(6):1901-10. PubMed ID: 10854213 [TBL] [Abstract][Full Text] [Related]
52. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome. Hertz JM; Juncker I; Persson U; Matthijs G; Schmidtke J; Petersen MB; Kjeldsen M; Gregersen N Hum Mutat; 2001 Aug; 18(2):141-8. PubMed ID: 11462238 [TBL] [Abstract][Full Text] [Related]
53. Somatic deletion of the 5' ends of both the COL4A5 and COL4A6 genes in a sporadic leiomyoma of the esophagus. Heidet L; Boye E; Cai Y; Sado Y; Zhang X; Fléjou JF; Fékété F; Ninomiya Y; Gubler MC; Antignac C Am J Pathol; 1998 Mar; 152(3):673-8. PubMed ID: 9502408 [TBL] [Abstract][Full Text] [Related]
54. Spectrum of COL4A5 mutations in Finnish Alport syndrome patients. Martin P; Heiskari N; Pajari H; Grönhagen-Riska C; Kääriäinen H; Koskimies O; Tryggvason K Hum Mutat; 2000 Jun; 15(6):579. PubMed ID: 10862091 [TBL] [Abstract][Full Text] [Related]
55. Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele. Guo C; Van Damme B; Vanrenterghem Y; Devriendt K; Cassiman JJ; Marynen P J Clin Invest; 1995 Apr; 95(4):1832-7. PubMed ID: 7706490 [TBL] [Abstract][Full Text] [Related]
56. COL4A5 gene deletion and production of post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kalluri R; Weber M; Netzer KO; Sun MJ; Neilson EG; Hudson BG Kidney Int; 1994 Mar; 45(3):721-6. PubMed ID: 8196274 [TBL] [Abstract][Full Text] [Related]
57. [Application of multiplex ligation-dependent probe amplification in gene diagnosis of X-linked Alport syndrome]. Zhang YQ; Zhao D; Yu LX; Ding J; Wang F Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2825-9. PubMed ID: 23290210 [TBL] [Abstract][Full Text] [Related]